Antares Pharma (AIS)
Antares Pharma EBITDA TTM: -2.948M
View AIS EBITDA TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
AIS EBITDA TTM Rankings
| Overall | 14th percentile | 3395 of 3956 |
| Sector | 42nd percentile | 290 of 504 in Healthcare |
| Industry | 28th percentile | 47 of 66 in Medical Instruments & Supplies |
AIS EBITDA TTM Range, Past 5 Years
| Minimum | -11.64M | Dec 2008 |
| Maximum | -2.948M | Mar 2012 |
| Average | -7.509M |
About EBITDA (TTM)
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization. EBITDA (TTM) is the sum of the last four quarters of EBITDA.
Investors often use EBITDA as a starting point for discounted cash flow analysis or to observe the performance of a business separately from its capital structure (debt vs equity financing structure).
Though EBITDA does form an excellent basis for cash flow analysis, some investors argue that it is a misleading measure since depreciation expenses are a real cost - old property, plant and equipment must eventually be replaced if a business plans to continue operations using those assets.
Learn More
You may also be interested in these AIS related companies
AIS News
@ANDISIK try to get timing/Entry better next time $AIS.Over history its proven 2 bounce back,so buy big dips not tops,n you'll luv this name
about 2 hours ago by HighGrowthFinancial
about 2 hours ago by HighGrowthFinancial
@HighGrowthFinancial $AIS is not hard but impossible to predict the price movement. Kills me that I could be making $ elsewhere.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
$AIS not buying this dip just yet, its been bouncing back from sub $3 everytime, not sure about this one though
about 3 days ago by HighGrowthFinancial
about 3 days ago by HighGrowthFinancial
@GPrime, $AIS, Example of making money elsewhere, bought SPPI yesterday at $10.76, its now at $11.20, a 4% gain.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
$AIS, really does test your patience. If it can't hold ~ $2.90, I'm going to start getting out. Buy back when lower or go make $ elsewhere.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
RT @casualtrader: Long $AIS Long will run into next earning date $CLSN Celsion buy @ 1,6 ~ 1,8 run up come by end of this year 8$ come
about 4 days ago by BioInvestor
about 4 days ago by BioInvestor
@casualtrader, $AIS. You should check out $SPPI, great company. I actually got back in today. ·
about 4 days ago by ANDISIK
about 4 days ago by ANDISIK
@markf @ANDISIK any other biotech ideas? Long $AIS, looking to initiate long position $ZLCS. Thoughts?
about 4 days ago by casualtrader
about 4 days ago by casualtrader
@markf $AIS not that I'm aware of.Just a safer long term biotech investment with huge potential. Don't need to put all $ in riskier biotechs
about 4 days ago by ANDISIK
about 4 days ago by ANDISIK
On 5/19/12 Columbine Capital Services upgraded $AIS from Neutral to Favorable.
about 6 days ago by ANDISIK
about 6 days ago by ANDISIK
RT @markf: $AIS on Aug 8th..?? on earnings day for $AIS next earning is Aug 7 or 8 2012 positive earning come 100%
about 10 days ago by BioInvestor
about 10 days ago by BioInvestor
Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical Sales and Marketing
May 15, 7:00AM Business Wire
May 15, 7:00AM Business Wire
Antares Pharma to Present at the 15th Annual Bank of America Merrill Lynch Health Care Conference
May 10, 7:00AM Business Wire
May 10, 7:00AM Business Wire
Antares Pharma Reports First Quarter 2012 Financial and Operating Results
May 08, 7:00AM Business Wire
May 08, 7:00AM Business Wire
Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva and Pfizer
Apr 26, 9:26AM Business Wire
Apr 26, 9:26AM Business Wire
Watson and Antares Announce the Introduction of Gelnique 3%™, for the Treatment of Overactive Bladder
Apr 26, 7:00AM PR Newswire
Apr 26, 7:00AM PR Newswire
Antares Pharma to Present at the 11th Annual Needham Healthcare Conference
Mar 28, 7:00AM Business Wire
Mar 28, 7:00AM Business Wire
Antares Pharma and Boston Scientific Look to Make Headway in Surging Medical Supplies Industry
Mar 22, 8:20AM Marketwire
Mar 22, 8:20AM Marketwire
Antares Pharma Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
Mar 12, 7:00AM Business Wire
Mar 12, 7:00AM Business Wire
Antares Pharma Appoints John J. Howarth Vice President of Corporate Affairs
Feb 27, 9:30AM Business Wire
Feb 27, 9:30AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AIS | 2.89 | +0.02 | +0.70% | 299.69M |
| AIRT | 9.250 | +0.17 | +1.87% | 22.66M |
| AIRM | 91.97 | -0.12 | -0.13% | 1.159B |
| AIR | 12.48 | -0.29 | -2.27% | 502.69M |
| AIQ | 1.05 | -0.02 | -1.87% | 55.99M |
| AMS | 3.09 | +0.03 | +0.98% | 14.24M |
| AMRS | 2.57 | +0.20 | +8.44% | 144.59M |
| AMRI | 2.71 | -0.05 | -1.81% | 83.39M |
| AMRC | 11.07 | -0.15 | -1.34% | 289.15M |
| AMPL | 0.185 | +0.01 | +2.83% | 10.38M |